Advertisement
Screener

ARVINAS, INC. (ARVN) Pre-Tax Margin

ARVINAS, INC. (ARVN) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 67.92%.
  • 2026-03-31: Pre-Tax Margin -368.59%.
  • 2025-12-31: Pre-Tax Margin -707.37%.
  • 2025-09-30: Pre-Tax Margin -83.05%.

Complete source-backed pre-tax margin history.

Available history
2017-09-30 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-3067.92%
2026-03-31-368.59%
2025-12-31-707.37%
2025-09-30-83.05%
2025-06-30-274.55%
2025-03-3144.01%
2024-12-31-76.86%
2024-09-30-47.46%
2024-06-30-45.75%
2024-03-31-273.91%
2023-12-31355.45%
2023-09-30-184.68%
2023-06-30-120.37%
2023-03-31-249.85%
2022-12-31-183.33%
2022-09-30-184.04%
2022-06-30-189.64%
2022-03-31-213.58%
2018-09-30-396.64%
2017-09-30-383.33%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-30.65%
2024-12-31-75.28%
2023-12-31-463.57%
2022-12-31-191.02%
2021-12-31-394.22%
2020-12-31-528.44%

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Evolus, Inc. (EOLS)United States$0.519B-13.32
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85